drugset / Trial / NCT02507050
Ivabradine and Post-revascularisation Microcirculatory Dysfunction
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of the study is to test whether, in patients with angina and flow limiting epicardial coronary artery disease, pre-treatment with Ivabradine, as opposed to beta blockers, will reduce post percutaneous coronary intervention induced microvascular dysfunction.
Timeline
- Start
- 2016-03
- Primary completion
- 2016-03
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ivabradine | Small molecule | 7.5 mg | — |